Catalyst Wire Dossier Catalyst Wire Dossier

AD504

· Apnimed
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AD504, covering 2022-09-02 to 2026-08-12. Get the full timeline:

Most recent: Clinical Trial Results: Parallel Arm Trial of AD109 and AD504 In Patients With OSA [Phase 2]

See pricing